Overview
Portfolio
More
The Venture Collective
New York, United States
We write high‑conviction checks at Pre‑Seed and Seed and keep follow‑on reserves through Series A, empowering founders solving the world’s biggest problems.
Portfolio
53+
Employees
30+
Founded
2019
AUM
N/A
Investment focus
Stages
No stages listed
Industries
No industries listedGeographic scope
United KingdomUnited States
Sources
The Venture Collective
We write high‑conviction checks at Pre‑Seed and Seed and keep follow‑on reserves through Series A, empowering founders solving the world’s biggest problems.
Portfolio
53+
Employees
30+
Founded
2019
AUM
N/A
Stages
No stages listed
Industries
No industries listedGeographic scope
United KingdomUnited States
Sources
Showing 24 of 43 matched portfolio companies
Arogga is a healthcare platform that enables users to upload prescriptions and order medications directly, ensuring confirmation by licensed pharmacists within 18 to 48 hours. The service addresses the challenge of accessing affordable healthcare products by providing a wide range of categories, including personal care, wellness supplements, and baby care, all delivered conveniently to customers' doorsteps.
Funding: $5.7M
Rough estimate of the amount of funding raised
The Venture Collective
The Venture Collective
Funding: $5.7M
Rough estimate of the amount of funding raised
Axiom Space develops human-rated space infrastructure and operates end-to-end missions to the International Space Station (ISS), addressing the need for commercial access to low-Earth orbit. The company is also constructing Axiom Station, the first commercial space station, and creating next-generation spacesuits for future lunar and deep-space exploration.
Funding: $606.0M
Rough estimate of the amount of funding raised
Aljazira CapitalBoryung Pharmaceutical
Aljazira CapitalBoryung Pharmaceutical
Funding: $606.0M
Rough estimate of the amount of funding raised
BIOS Health develops neural interfaces and AI technology to read and write neural data, enabling real-time analysis of the nervous system's signals. This approach addresses the malfunctioning signals that can lead to diseases, facilitating the creation of targeted pharmaceuticals and software-delivered therapies.
Funding: $25.1M
Rough estimate of the amount of funding raised
Funding: $25.1M
Rough estimate of the amount of funding raised
Brave Health is an online platform providing telehealth services for therapy and psychiatric medication management, ensuring easy access to clinically effective mental health care. By partnering with over 200 insurance plans, the platform addresses the challenge of limited access to mental health services, improving patient engagement and reducing hospital readmissions.
Funding: $59.4M
Rough estimate of the amount of funding raised
Town Hall Ventures
Town Hall Ventures
Funding: $59.4M
Rough estimate of the amount of funding raised
Develops scalable biocatalysis solutions that produce essential chemicals from sustainable carbon sources using engineered enzymes and whole-cell catalysts. This process reduces reliance on fossil fuels and enables environmentally friendly manufacturing by optimizing catalyst performance and integrating with existing production systems.
2048 Ventures
This company engineers modular immunotherapies for cancer treatment by screening millions of protein candidates in living cells. They utilize a high-throughput screening platform coupled with machine learning to rapidly identify and design optimal therapeutic candidates. This integrated approach accelerates the development timeline, delivering best-in-class immunotherapies faster for clinical application.
Funding: $3.6M
Rough estimate of the amount of funding raised
Funding: $3.6M
Rough estimate of the amount of funding raised
Elysium Health develops science-based dietary supplements and anti-aging products that target cellular aging by replenishing NAD+ levels and supporting mitochondrial function. Their offerings, including the at-home biological age test Index, provide measurable insights into aging processes and promote overall health and longevity.
Epoch Biodesign utilizes proprietary AI-designed enzymes to deconstruct waste materials at the molecular level. This biological process yields virgin-quality, recycled polymers, starting with nylon 6,6, at ultra-low emissions. The company is scaling this enzymatic recycling technology to support global manufacturing of circular materials.
Funding: $16.0M
Rough estimate of the amount of funding raised
Funding: $16.0M
Rough estimate of the amount of funding raised
FlyteHealth offers a technology‑enabled obesity and cardiometabolic care program for large employers, insurers, and government health plans. The service provides remote physician‑supervised, prescription‑grade pharmacotherapy, digital coaching, and continuous outcome monitoring through a HIPAA‑compliant platform, while analytics quantify cost avoidance and ROI for the covered population.
Fork and Good develops cultivated meat production methods to improve sourcing practices and product quality. The company focuses on creating high-quality meat while minimizing the environmental impact associated with traditional livestock farming. Their goal is to achieve cost parity to make sustainable meat accessible for everyday consumption.
Funding: $22.0M
Rough estimate of the amount of funding raised
Funding: $22.0M
Rough estimate of the amount of funding raised
Gravitics designs and manufactures large-scale space platforms that provide essential infrastructure for commercial, civil, and defense applications in orbit. Their technology addresses the need for reliable logistics and power solutions, enabling human and robotic activities in space while fostering a sustainable space economy.
Hale has developed a digital drug therapy device that automatically adjusts nicotine intake over time, utilizing a patent-pending design to facilitate gradual de-addiction. This connected device, paired with a mobile app for usage tracking, addresses the challenge of nicotine addiction by providing a low-risk alternative to traditional cessation methods.
Funding: $2.4M
Rough estimate of the amount of funding raised
Funding: $2.4M
Rough estimate of the amount of funding raised
Helaxy develops fluidic cards for next-generation sequencing (NGS) library preparation, enabling clinicians to automate sample processing with minimal hands-on time. This technology eliminates manual pipetting errors and reduces reagent waste, making NGS accessible in hospitals and laboratories worldwide.
Founded 2020
HEO provides non-Earth imaging (NEI) services using a network of 46 in-orbit sensors to capture high-resolution imagery of space objects, including satellites and debris. This technology enables commercial, government, and defense organizations to monitor and assess the status of these objects, enhancing space situational awareness and operational decision-making.
Funding: $12.0M
Rough estimate of the amount of funding raised
Funding: $12.0M
Rough estimate of the amount of funding raised
InGel Therapeutics develops engineered cell therapies targeting retinal degeneration by utilizing highly pure precursor cells for neuroprotection. The company pairs these cells with a biomimetic hydrogel delivery platform that mimics the human vitreous for optimal in vivo performance. This dual innovation addresses limitations in current regenerative approaches for diseases like Retinitis Pigmentosa and Dry AMD.
Funding: $9.5M
Rough estimate of the amount of funding raised
Funding: $9.5M
Rough estimate of the amount of funding raised
Laguna Bio develops engineered, highly attenuated microbial platforms that activate innate T‑cell subsets (γδ, MAIT, NKT) directly in patients to generate robust anti‑tumor immunity. By delivering precise immune‑stimulating signals in vivo, its QUAIL and IBIS platforms aim to provide scalable, off‑the‑shelf immunotherapies for high‑risk hematologic malignancies and solid tumors without the complexity of ex vivo cell engineering.
Funding: $11.7M
Rough estimate of the amount of funding raised
SOSV
SOSV
Funding: $11.7M
Rough estimate of the amount of funding raised
Life Biosciences is developing cellular rejuvenation therapies that target specific biological mechanisms of aging to reverse and prevent age-related diseases. Their approach aims to provide therapeutic options for chronic conditions that currently lack effective treatments.
Funding: $175.2M
Rough estimate of the amount of funding raised
Alpha Wave Ventures
Alpha Wave Ventures
Funding: $175.2M
Rough estimate of the amount of funding raised
The startup develops a fintech platform that provides payment applications enabling small businesses to accept cashless transactions through mobile devices, payment stickers, or card readers. This technology facilitates faster and more cost-effective payment processing, allowing independent businesses to receive funds instantly.
30+
1K+Approximate amount of employees
Funding: $7.4M
Rough estimate of the amount of funding raised
Portage Ventures
Portage Ventures
Funding: $7.4M
Rough estimate of the amount of funding raised
Lyric Bio develops palm‑sized bioreactors that use a proprietary laser‑printed cellular substrate to grow donor‑derived B cells at ultra‑high density, enabling continuous production of human immunoglobulin from a single plasma donation. This tissue‑engineered platform can generate thousands of IVIg doses per donor, reducing reliance on plasma collection, lowering manufacturing costs, and improving product consistency for pharmaceutical manufacturers and healthcare providers.
Mach supplies commercial, full-stack autonomy solutions for off-road vehicle OEMs operating in demanding environments. Their integrated hardware and software suite includes perception, navigation, and fleet management tools designed for scalable deployment. This technology enables OEMs to accelerate their autonomy roadmap from sub-system integration to fully driverless operation.
MDisrupt operates an expert matching platform that utilizes AI-driven algorithms to connect healthcare and life sciences companies with vetted professionals across 35 clinical specialties. This platform addresses the challenge of sourcing experienced talent quickly by managing logistics such as contracts, payments, and compliance, enabling faster project initiation and execution.
Funding: $10.0M
Rough estimate of the amount of funding raised
American Heart Association Ventures
American Heart Association Ventures
Funding: $10.0M
Rough estimate of the amount of funding raised
The startup provides bioinspired and biodegradable insect repellents that utilize natural ingredients to replace traditional diethyltoluamide-based products. This approach reduces reliance on harmful chemicals while offering effective protection against insects.
3+
10+Approximate amount of employees
Funding: $5.7M
Rough estimate of the amount of funding raised
Funding: $5.7M
Rough estimate of the amount of funding raised
The startup operates a building intelligence platform that utilizes data from IoT devices to monitor and analyze building performance metrics. This technology enhances operational efficiency and sustainability, enabling real estate and facilities teams to maintain healthier and more profitable environments.
Funding: $150.4M
Rough estimate of the amount of funding raised
Funding: $150.4M
Rough estimate of the amount of funding raised
Provides a sensor-based AI system for monitoring breeding processes in livestock. This technology improves reproductive efficiency and animal health by delivering real-time data and insights, enabling farmers to optimize breeding strategies and reduce costs.
Funding: $31.9M
Rough estimate of the amount of funding raised
83North
83North
Funding: $31.9M
Rough estimate of the amount of funding raised
Showing 10 of 10 unmatched portfolio companies